Garey Mazowita. Show Affiliations »
Abstract
Mesh: See more » Cardiovascular Diseases/prevention & controlDecision MakingDyslipidemias/complicationsDyslipidemias/drug therapyHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic usePractice Guidelines as TopicPrimary Health CareRisk Assessment
Substances: See more » Hydroxymethylglutaryl-CoA Reductase Inhibitors
Year: 2005 PMID: 16275979 PMCID: PMC1277054 DOI: 10.1503/cmaj.1050121
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262